The Division of Cancer Treatment & Diagnosis (DCTD), National Cancer Institute is actively exploring drug molecular mechanisms in conjunction with tumor gene expression, mutation and protein profiling to pair the development of newer anticancer agents with specific molecular vulnerabilities in the precision oncology medicine setting. The Leidos Biomedical program in molecular pharmacology at the Frederick [...]
The Position We are seeking a Senior Scientific Researcher in the Department of Molecular Biology to support the production and optimization of genetically-modified cellular models. This position will be within the newly-established Cell Engineering Lab, wherein she/he will facilitate the design, execution, and validation of cell line engineering projects initiated by researchers across Genentech -- [...]
The research to be carried out focuses on the micro-environmental and epigenetic regulation of disseminated cancer cell dormancy and metastasis initiation. The project will focus on the mechanisms by which signals from the micro-environment reprogram tumor cells into dormancy. The project will focus on identifying signals produced by organ specific macrophages that impinge on solitary [...]
The Section of Hematology/Oncology has a proud and long tradition of excellence in research-based patient care and clinical discovery. Ranked among the finest cancer programs in the country, the Section is comprised of nationally and internationally known faculty with expertise in all major types of malignancies, blood disorders, and experimental therapies. Principal contributions are scientific [...]
The candidate will work in the High-Throughput Screening Core (HTSC) in the Perelman School of Medicine (PSOM). He/she will work with the Scientific and Technical Directors of the core to further design, to optimize and validate biological assays in high-density formats (i.e. 384 well microtiter plates) for primary human cancers that can be screened against [...]
